S-4 Filing

The approximately $1.2 billion transaction is the foundation of Waldencast’s strategy to create a global multi-brand beauty and wellness platform.

As announced last month, the transaction is expected to deliver up to $412 million in gross cash proceeds to Akili.

As announced in November, the estimated post-transaction equity value of the combined company is approximately $500 million, assuming no redemptions, with $200 million cash on hand after closing.

As announced in September, the deal would be funded through a combination of Cartesian’s $345 million cash in trust and approximately $165 million in a fully committed PIPE.

The deal values the combined company at $1.75 billion.

The transaction will be financed by ABIC’s $400 million cash in trust, a $100 million investment from Harley-Davidson, and a $100 million investment from KYMCO through a PIPE.

The proposed business combination is expected to provide approximately $107 million in gross proceeds from the cash held in trust by OTR. 

The transaction has an implied pro forma enterprise value of approximately $1.7 billion and pro forma equity value of approximately $2 billion.

The deal carries a pro forma equity value of $561 million.

As announced in December, the transaction would deliver approximately $512 million in cash to Eve. The pro forma equity value of the combined company was cited as $2.9 billion, assuming no SPAC share redemptions.